Drugs / Vuloven
last change Oct 2011 re-read 3 minutes ago

Vuloven

Developed for
cerebrovascular disorder
Investigated by
Xijing Hospital

Trials 1

20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01192581 Aug 2010 → Apr 2011 cerebrovascular disorder Xijing Hospital Unknown No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Vuloven “study drug (hydroxyethyl starch 130/0.4 and sodium chloride injection, Vuloven)” NCT01192581 ↗
Known as hydroxyethyl starch 130/0.4 and sodium chloride injection “study drug (hydroxyethyl starch 130/0.4 and sodium chloride injection, Vuloven)” NCT01192581 ↗
Route Intravenous “administrated intravenously for 7 days” NCT01192581 ↗